当前位置:
X-MOL 学术
›
Cancer Genom. Proteom.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV+ and HPV- Squamous Cell Carcinoma.
Cancer Genomics & Proteomics ( IF 2.5 ) Pub Date : 2020-8-30 , DOI: 10.21873/cgp.20214 Benjamin Kansy 1 , Christoph Aderhold 2 , Lena Huber 2 , Sonja Ludwig 2 , Richard Birk 2, 3 , Anne Lammert 2 , Stephan Lang 4 , Nicole Rotter 2 , Benedikt Kramer 2
Cancer Genomics & Proteomics ( IF 2.5 ) Pub Date : 2020-8-30 , DOI: 10.21873/cgp.20214 Benjamin Kansy 1 , Christoph Aderhold 2 , Lena Huber 2 , Sonja Ludwig 2 , Richard Birk 2, 3 , Anne Lammert 2 , Stephan Lang 4 , Nicole Rotter 2 , Benedikt Kramer 2
Affiliation
We investigated the expression patterns of cluster of differentiation (CD) 44 and amphiregulin (AREG), two signaling molecules essential for cell proliferation and differentiation, under the influence of selective tyrosine kinase inhibitors (TKIs) in human papillomavirus (HPV)+ and HPV- squamous carcinoma cell lines.
中文翻译:
用选择性酪氨酸激酶抑制剂治疗的HPV +和HPV-鳞状细胞癌中CD44和AREG的表达模式。
我们研究了分化(CD)44和双调蛋白(AREG),两个信令细胞增殖和分化所必需的分子簇的表达模式,选择性酪氨酸激酶在人乳头瘤病毒(HPV)抑制剂(TKI)的影响下,+和HPV -鳞状癌细胞系。
更新日期:2020-08-31
中文翻译:
用选择性酪氨酸激酶抑制剂治疗的HPV +和HPV-鳞状细胞癌中CD44和AREG的表达模式。
我们研究了分化(CD)44和双调蛋白(AREG),两个信令细胞增殖和分化所必需的分子簇的表达模式,选择性酪氨酸激酶在人乳头瘤病毒(HPV)抑制剂(TKI)的影响下,+和HPV -鳞状癌细胞系。